Target intelligence / Profile preview

MicroRNA 942 (miR-942 (or MIR942))

Target
miR-942 (or MIR942)
Molecular classification
MicroRNA, Non-coding RNA, Other
01

Overview

MicroRNA 942 is a short, non-coding RNA molecule (miRNA) transcribed from the MIR942 gene in humans. It regulates gene expression by binding to complementary sequences in messenger RNAs, thereby inhibiting their translation or promoting degradation. Two mature forms, miR-942-3p and miR-942-5p, are produced from the precursor hairpin. Both have been implicated in the regulation of cell proliferation, migration, apoptosis, and invasion in a broad range of cancers, often acting as an **oncogene** (tumor promoter) but with some evidence of tumor suppressor roles in a context-dependent manner. One of its best-characterized targets is *FOXA2*, a transcription factor, which mediates much of its effect in breast cancer and possibly other tumors. miR-942's expression levels are frequently dysregulated in malignancy, making it a promising *biomarker* for diagnosis and prognosis, though there is little evidence that it functions as a classical direct drug target or receptor

Other names
hsa-mir-942MIRN942MIR942mir-942MicroRNA 942miR-942-3p (major mature form)miR-942-5p (alternate mature form)
02

Mechanism of action

Not directly druggable; miR-942 acts by *binding target mRNAs* (e.g. FOXA2) to inhibit their translation or cause degradation, thereby influencing signaling networks, cell cycle, apoptosis, and epithelial-mesenchymal transition (EMT)

03

Biological functions

Post-transcriptional regulation of gene expressionModulation of cell proliferationRegulation of cell apoptosisPromotion/inhibition of cell migration and invasionRegulation of signaling pathways (including TGF-beta, Wnt, JAK/STAT, PI3K/AKT, Hippo, NF-κB, lectin pathway, interferon-gamma, G protein-coupled receptor signaling, mesodermal commitment, and T-cell receptor signaling)
04

Disease associations

Cancer (notably breast, bladder, esophageal, cervical, gastric, colorectal, hepatocellular, lung, oral, osteosarcoma, ovarian, pancreatic, renal, prostate, and melanoma)Potential roles in inflammation (based on immune pathway involvement)
05

Safety considerations

*Therapeutic challenges* include the specificity, efficacy, and safety of potential miRNA-modulating drugs, off-target effects, stability/delivery of oligonucleotide therapies, and poorly understood long-term effects
06

Interacting drugs

None clearly established; microRNAs are not classical drug targets, but may be targeted or measured in *experimental* oligonucleotide therapies or considered for RNA-based therapeutics
07

Biomarkers

Circulating miR-942 (especially miR-942-5p and miR-942-3p) are proposed as **diagnostic and prognostic biomarkers** for several cancers

Beyond the preview

Go deeper on MicroRNA 942 (miR-942 (or MIR942)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 942 (miR-942 (or MIR942)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call